Skip to content
Review Open access

Cancer-associated fibroblasts: origins, functional heterogeneity and therapeutic potential

Oct 2026 · Signal Transduction and Targeted Therapy · Vol 11 · 0 citations · 374 references
Medicine

TL;DR

This Review dissects the multifaceted roles of CAFs, from their promotion of cancer cell proliferation, invasion and angiogenesis through secreted factors and extensive extracellular matrix (ECM) remodeling, to their profound influence on the immune landscape.

Abstract

Cancer-associated fibroblasts (CAFs) are integral components of the tumor microenvironment (TME) and are increasingly recognized as critical regulators of nearly every hallmark of cancer. Once viewed as a uniform, protumorigenic cell type, it is now clear that CAFs comprise a spectrum of dynamic and plastic functional states with both tumor-promoting and tumor-restraining capacities. This functional duality, conceptualized within the framework of cancer as a “wound that fails to heal”, is dictated by their diverse cellular origins, the specific activation pathways engaged (such as TGF-β and PDGF), and the evolving cues from the TME. In this Review, we dissect the multifaceted roles of CAFs, from their promotion of cancer cell proliferation, invasion and angiogenesis through secreted factors and extensive extracellular matrix (ECM) remodeling, to their profound influence on the immune landscape. We detail how distinct CAF subsets, such as myofibroblastic (myCAFs) and inflammatory (iCAFs) CAFs, orchestrate an immunosuppressive niche and contribute to therapeutic resistance. We also explore the compelling evidence for tumor-suppressive CAF functions, which have catalyzed a paradigm shift in therapeutic strategies—moving away from indiscriminate CAF ablation towards nuanced approaches aimed at reprogramming their state. These strategies include modulating key signaling pathways, normalizing the CAF-remodeled ECM, and exploiting unique metabolic vulnerabilities. Finally, we discuss how advances in single-cell and spatial transcriptomics are resolving this complexity, paving the way for the development of precision therapies that can selectively neutralize pro-tumorigenic CAF activities while harnessing their beneficial functions to improve patient outcomes.

Read PDF

Similar papers

Review Open access Oct 2026

Cancer-associated fibroblasts: multifaceted regulators of the tumor microenvironment and emerging therapeutic targets

Cancer-associated fibroblasts (CAFs) are a heterogeneous population of nonmalignant stromal cells that influence tumor progression and treatment response. They can arise from resident fibroblasts and other progenitor populations, with their relative contributions varying across tumor types and experimental settings. CA...

Jin-Song Yu, Han Yang, Xiao-Fang Zhu · 0 citations
Review Nov 2026

Running title: The plasticity of CAFs in cancer development.

Cancer is among the leading causes of death worldwide. The tumor microenvironment is a dynamic, multifaceted milieu where the cancer cells interact with diverse components. Resident stromal cell-derived cancer-associated fibroblasts are central to the crosstalk. There is variability in the origin, phenotype, and functi...

B. Bakhshandeh, Z. Jahanafrooz, Ghazal Ghajari et al. · 0 citations
Review Open access Nov 2026

From CAF heterogeneity to immune modulation and therapeutic targeting: a subtype-based framework

Cancer-associated fibroblasts (CAFs) are the predominant stromal component in solid tumors, contributing to extracellular matrix (ECM) remodeling, immune regulation, and therapy responses. Once considered homogeneous, CAFs are now recognized as a heterogeneous population comprising subtypes with distinct phenotypes and...

T. Zhang, S. Jiang · 0 citations
Review Nov 2026

Cancer-Associated Fibroblasts and Tertiary Lymphoid Structures: Critical Regulators in the Tumor Immune Microenvironment.

Tumor-associated fibroblasts (CAFs) are a highly heterogeneous cell population. Although previous studies have largely associated CAFs with tumor invasion and drug resistance, recent evidence has linked certain CAFs subsets to tertiary lymphoid structures (TLS) within the tumor immune microenvironment. TLS are lymphocy...

Ming Chen, Fu-Hao Xu, Jie Liu et al. · 0 citations
Review Open access Oct 2026

From CAF subtypes to clinically relevant states: cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

This review synthesizes evidence on fibroblast origins, canonical and recently reported states, and the signals that drive state transitions and examines CAF functions in extracellular matrix organization, tumor-cell plasticity and dissemination, metabolic support and immune regulation.

Yi Hao, Yi Wang, Qin-Yang Du et al. · 0 citations
Sep 2026

Abstract A013: Tumor microenvironmental metabolites regulate cancer-associated fibroblast heterogeneity

Pancreatic ductal adenocarcinoma (PDAC) is characterized by a prominent desmoplastic response with a high abundance of cancer-associated fibroblasts (CAFs). CAFs are a functionally and transcriptionally heterogeneous population of cells and include inflammatory CAFs (iCAFs), thought to promote tumor growth via the se...

Simon Schwoerer, Chu-Fan Cai, Jessica Stradley et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.